Supervisory board

EQS-News: Northern Data AG holds Annual General Meeting

Retrieved on: 
Friday, September 13, 2024
Supervisory board, ETR, Supervision, NB2, Annual general meeting

The issuer is solely responsible for the content of this announcement.

Key Points: 
  • The issuer is solely responsible for the content of this announcement.
  • Frankfurt/Main – 13 September 2024 – Northern Data AG (ETR: NB2 ) (“Northern Data Group” or “the Group”) successfully concluded its 2024 Annual General Meeting, which was virtually broadcast via livestream, for its duly registered shareholders or their proxies on the company’s website.
  • Shareholders and their proxies had the opportunity to ask questions, which were answered in detail by Aroosh Thillainathan, Group CEO and Chairman of the Management Board, and by Dr. Tom Oliver Schorling, Chairman of the Supervisory Board.
  • All resolutions proposed by the Management Board and Supervisory Board were approved by the shareholders.

Wolters Kluwer nominates Anjana Harve for appointment to the Supervisory Board

Retrieved on: 
Friday, September 13, 2024
Computer science, Engineering, University, MBA, CIO, Fresenius Medical Care, Bangalore University, Supervisory board, Information management, Novartis, Health care, EGM, Hill-Rom, Wolters Kluwer, Executive

Alphen aan den Rijn – September 13, 2024 - Wolters Kluwer, a global leader in professional information, software solutions, and services, today announced the nomination of Ms. Anjana Harve for appointment to its Supervisory Board.

Key Points: 
  • Alphen aan den Rijn – September 13, 2024 - Wolters Kluwer, a global leader in professional information, software solutions, and services, today announced the nomination of Ms. Anjana Harve for appointment to its Supervisory Board.
  • Chair of the Supervisory Board, Ann Ziegler, stated, “We are excited to nominate Anjana Harve for appointment to Wolters Kluwer's Supervisory Board.
  • Her extensive experience as Chief Information Officer in various industries, including Healthcare, makes her an excellent candidate and addition to our Supervisory Board.
  • At the Extraordinary General Meeting of Shareholders on October 28, 2024, we will propose to appoint Ms. Anjana Harve as member of the Supervisory Board.

EQS-News: Change in the Chief Financial Officer at Biotest AG

Retrieved on: 
Thursday, September 12, 2024
Supervisory board, Interim

The Supervisory Board of Biotest AG announced today that the former Chief Financial Officer, Ms. Ainhoa Mendizabal Zubiaga, is leaving the company for personal reasons.

Key Points: 
  • The Supervisory Board of Biotest AG announced today that the former Chief Financial Officer, Ms. Ainhoa Mendizabal Zubiaga, is leaving the company for personal reasons.
  • As part of this change, we welcome Mr. Martin Möller (52) as the new Interim Chief Financial Officer.
  • We are pleased to have Mr. Möller on board as an experienced leader to support us during this transition period.
  • The company would like to thank both individuals and looks forward with confidence to the next six months under Mr. Möller's leadership.

EQS-News: Pentixapharm Holding AG, a Subsidiary of Eckert & Ziegler SE, Plans IPO on the Prime Standard of the Frankfurt Stock Exchange

Retrieved on: 
Thursday, September 12, 2024
Radiopharmaceutical, AG, USD, Research, University, NHL, Bone marrow, Patient, Annual general meeting, FDA, Supervisory board, Diagnosis, Primary aldosteronism, Cancer, Food, IPO, Hypertension, Frankfurt Stock Exchange, CXCR4, IIS, Regulated market, Radionuclide, AMERICA, Bookrunner, Patent, Pharmaceutical industry

Pentixapharm Holding AG, a Subsidiary of Eckert & Ziegler SE, Plans IPO on the Prime Standard of the Frankfurt Stock Exchange

Key Points: 
  • Pentixapharm Holding AG, a Subsidiary of Eckert & Ziegler SE, Plans IPO on the Prime Standard of the Frankfurt Stock Exchange
    The issuer is solely responsible for the content of this announcement.
  • While Eckert & Ziegler's core business revolves around the production and distribution of radioisotopes, Pentixapharm is dedicated to the development and approval of new radiopharmaceuticals.
  • The planned IPO enables Pentixapharm to target investors specifically interested in the company's innovative and forward-looking pipeline.
  • As an independent company, Pentixapharm can now operate more flexibly to advance its research and development projects.

EQS-News: Bastei Lübbe AG: Dividend almost doubled to 30 cents per share and positive financial outlook confirmed

Retrieved on: 
Thursday, September 12, 2024
EUR, Annual, Annual general meeting, Book, Growth, Supervisory board, Publishing, Optimism, CFO, Speech, Executive, Management

Bastei Lübbe AG (ISIN DE000A1X3YY0 ), a general-interest publisher held its Annual General Meeting in presence yesterday.

Key Points: 
  • Bastei Lübbe AG (ISIN DE000A1X3YY0 ), a general-interest publisher held its Annual General Meeting in presence yesterday.
  • As usual, shareholders followed the explanations provided by the Supervisory Board and the Executive Board on the past financial year 2023/2024 and the outlook for the company's future development.
  • The community principle also results in direct-to-commerce potential, which Bastei Lübbe is successfully tapping into with store start-ups and expansions.
  • The Executive Board expressed optimism for the further course of the current financial year and confirmed its revenue and profit forecast.

EQS-News: Executive Board of Symrise AG reorganized

Retrieved on: 
Thursday, September 12, 2024
Taste, Supervisory board, Odor, Foodservice, Food, Nutrition and Health, Family, Nutrition, Nursing

Walter Ribeiro appointed Board Member for the Taste, Nutrition & Health segment

Key Points: 
  • Walter Ribeiro appointed Board Member for the Taste, Nutrition & Health segment
    The Supervisory Board of Symrise AG has appointed Walter Ribeiro to the Executive Board with effect from September 15, 2024.
  • At the same time, Dr. Jörn Andreas steps down as a member of the Executive Board of Symrise AG as of September 30, 2024 to pursue his professional career outside Symrise.
  • Michael König, Chairman of the Supervisory Board of Symrise AG: "With Walter Ribeiro, another internationally experienced manager from within the company's own ranks has been appointed to the Executive Board.
  • Together in the Executive Board, we will now work on the successful further development of Symrise.

EQS-News: STEMMER IMAGING AG: Management Board and Supervisory Board recommend acceptance of MiddleGround Capital’s voluntary public takeover offer

Retrieved on: 
Wednesday, September 11, 2024
EUR, Puchheim, Growth, Supervisory board, Internet, Management, Supervision, Bidding, Partnership, Property management

After careful and thorough examination of the offer document published on September 2, 2024, the Management Board and Supervisory Board recommend in their Joint Reasoned Statement that the shareholders of STEMMER IMAGING accept the offer.

Key Points: 
  • After careful and thorough examination of the offer document published on September 2, 2024, the Management Board and Supervisory Board recommend in their Joint Reasoned Statement that the shareholders of STEMMER IMAGING accept the offer.
  • The members of the Management Board of STEMMER IMAGING AG have accepted the takeover offer for the shares held by them.
  • The Management Board and Supervisory Board are of the opinion that the offer is in line with the interests and objectives of STEMMER IMAGING, the shareholders of STEMMER IMAGING as well as the employees within STEMMER IMAGING Group to a significant extent.
  • Any decision regarding the acceptance or non-acceptance of the takeover offer should be based solely on a careful consideration of the offer document published on www.project-oculus.de and the joined reasoned statement by the management board and supervisory board of STEMMER IMAGING AG published on www.stemmer-imaging.com in the “Investor Relations” section.

Commerzbank Aktiengesellschaft: CEO not to seek extension of his contract

Retrieved on: 
Tuesday, September 10, 2024
Commerzbank, Supervisory board, Risk management

Manfred Knof, CEO of Commerzbank AG, has today informed Jens Weidmann, Chairman of the Supervisory Board, that he will fulfil his contract, which runs until the end of December 2025, but won’t be at the disposal of Commerzbank beyond that date.

Key Points: 
  • Manfred Knof, CEO of Commerzbank AG, has today informed Jens Weidmann, Chairman of the Supervisory Board, that he will fulfil his contract, which runs until the end of December 2025, but won’t be at the disposal of Commerzbank beyond that date.
  • The Supervisory Board of Commerzbank AG will commence an orderly search process for the successor to the role of CEO immediately.
  • These forward-looking statements are based on the management’s current plans, expectations, estimates and projections.
  • Commerzbank has no obligation to update or release any revisions to the forward-looking statements contained in this release to reflect events or circumstances after the date of this release.

EQS-News: NEON EQUITY completes new appointments to the Supervisory Board - Jörg Wisotzki becomes new member

Retrieved on: 
Tuesday, September 10, 2024
EQUITY, Supervisory board, ESG, NEON, Security (finance)

Frankfurt, September 10, 2024 - NEON EQUITY AG (NEON EQUITY ISIN: DE000A3DW408) has completed the reappointment of its Supervisory Board and is thus ideally positioned to implement its impact investing strategy.

Key Points: 
  • Frankfurt, September 10, 2024 - NEON EQUITY AG (NEON EQUITY ISIN: DE000A3DW408) has completed the reappointment of its Supervisory Board and is thus ideally positioned to implement its impact investing strategy.
  • At the request of the company, Jörg Wisotzki was newly appointed to the Supervisory Board of NEON EQUITY by the Frankfurt District Court.
  • In addition to Eva Katheder and Boris Staab, who have both been members of the NEON EQUITY Supervisory Board since the summer, the Supervisory Board is now completely new with Jörg Wisotzki.
  • NEON EQUITY expects this to provide valuable impetus and support for the company's further growth strategy in the area of impact investing.

EQS-News: HMS Bergbau AG: Contract of CEO Dennis Schwindt extended

Retrieved on: 
Tuesday, September 10, 2024
EUR, Growth, Supervisory board, HMS Group, Mineral, Coal, HMS, Marketing

Berlin, 10 September 2024: The Supervisory Board of HMS Bergbau AG, an international, independent raw materials trading and marketing company, announces the reappointment of Mr Dennis Schwindt as Chief Executive Officer (CEO) for a further five-year period ending 31 August 2029.

Key Points: 
  • Berlin, 10 September 2024: The Supervisory Board of HMS Bergbau AG, an international, independent raw materials trading and marketing company, announces the reappointment of Mr Dennis Schwindt as Chief Executive Officer (CEO) for a further five-year period ending 31 August 2029.
  • “In his role as the CEO of HMS Bergbau AG, Mr Schwindt has done an exceptional job over these past few years and played a major role in growing the Company’s sales and earnings to over EUR 1 billion.
  • We are pleased to have achieved this by extending Mr Schwindt’s contract,” said Heinz Schernikau, Company founder and Chairman of the Supervisory Board of HMS Bergbau AG.
  • I look forward to continuing my work with the Management Board, the Supervisory Board, and the entire international team,” said Dennis Schwindt, CEO of HMS Bergbau AG.